Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
Net Income (Common)
Arix Bioscience PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arix Bioscience PLC
LSE:ARIX
|
Net Income (Common)
-£27.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Net Income (Common)
$380.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
3i Group PLC
LSE:III
|
Net Income (Common)
£4.5B
|
CAGR 3-Years
85%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
Schroders PLC
LSE:SDR
|
Net Income (Common)
£402.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Net Income (Common)
£472.2m
|
CAGR 3-Years
45%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
See Also
What is Arix Bioscience PLC's Net Income (Common)?
Net Income (Common)
-27.6m
GBP
Based on the financial report for Dec 31, 2022, Arix Bioscience PLC's Net Income (Common) amounts to -27.6m GBP.
What is Arix Bioscience PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-30%
Over the last year, the Net Income (Common) growth was 55%. The average annual Net Income (Common) growth rates for Arix Bioscience PLC have been 27% over the past three years , -30% over the past five years .